Overview of Dr. Fojo
Dr. Antonio Fojo is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 43 years. He is one of 116 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 378 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
161 Fort Washington Ave
New York, NY 10032
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1978 - 1982
- University of Miami Leonard M. Miller School of MedicineClass of 1977
Certifications & Licensure
- NY State Medical License 2015 - 2025
- MD State Medical License 1983 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) Start of enrollment: 2019 Jun 17
Roles: Sponsor-Investigator, Principal Investigator, Contact
- Entinostat Neuroendocrine (NE) Tumor Start of enrollment: 2017 Dec 23
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- 135 citationsMicrotubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteinsMarianne S. Poruchynsky, Edina Komlodi-Pasztor, Shana Y. Trostel, Julia Wilkerson, Marie Regairaz
Proceedings of the National Academy of Sciences of the United States of America. 2015-02-03 - 36 citationsInhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndromePing Yuan Wang, Jie Li, Farzana L. Walcott, Ju-Gyeong Kang, Matthew F. Starost
The Journal of Clinical Investigation. 2016-11-21 - 488 citationsRedistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Hum...Kevin C. Conlon, Enrico Lugli, Hugh C. Welles, Steven A. Rosenberg, Antonio Tito Fojo
Journal of Clinical Oncology. 2015-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: